The Colorectal Cancer Landscape
Incidence of Colorectal Cancer continues to rise, with the disease now ranked 3rd for prevalence amongst cancer indications and cases predicted to increase by 63% by 2040.
With exclusive data from Beacon, this report contains:
- Analysis of Colorectal Cancer assets advancing towards late-phase clinical trials
- Insights into promising novel targets across all drug modalities
- Overview of recent approvals in the Colorectal Cancer treatment landscape
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
